Phlow
  • About
    • Who We Are
    • Our Impact
    • Leadership
    • Careers
  • Areas of Excellence
    • Small Molecule
    • Government/NGO
  • U.S. Facilities
    • Industrial Footprint
    • SAPIR®
  • News
  • Collaborate
Select Page

National Essential Medicine Shortage Awareness Day Highlights a Critical Public Health Issue that Demands America’s Attention

2021, Press Releases

RICHMOND, Va., September 8, 2021 – Phlow, a U.S.-based, essential medicines impact company, today announced its support of the first-ever National Essential Medicine Shortage Awareness Day. This observance was created to educate the public about the ongoing crisis of...

Observance Day Overview

2021, Other News

Phlow Corp. CEO Publishes Op-Ed in Harvard Business Review

2021, Phlow™ in the News

Source: Harvard Business Review Eric Edwards, M.D., Ph.D., co-founder, President, and CEO of Phlow, has published an op-ed titled “The U.S. Needs to Reimagine Its Pharma Supply Chain” in Harvard Business Review about essential medications currently in shortage. “When...

Phlow Corp. Receives The U.S Department of Health and Human Services, Office of Small and Disadvantaged Business Utilization, Small Business Prime Contractor of the Year Award

2021, Press Releases, Updates From Phlow™

RICHMOND, Va., July 19, 2021 – The U.S. Department of Health and Human Services (HHS), recently announced that Phlow Corp. has been awarded the Office of Small and Disadvantaged Business Utilization (OSDBU), Small Business Prime Contractor of the Year Award. Phlow...

How Pharmaceutical Innovation is Transforming Petersburg

2021, Phlow™ in the News

A surge of fresh energy and opportunities are attracting new residents and businesses to Virginia’s Gateway Region. Here’s what it means for the area – and why you might want to come along for the ride. Source: Livability From targeted agents used in precision...
« Older Entries
Next Entries »

Recent Posts

  • Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP
  • Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing
  • Phlow Corp. CEO Outlines Path to Pharmaceutical Sovereignty in Testimony Before U.S. Senate
  • Safeguarding Essential Medicines in an Uncertain World
  • Phlow Corp. Congratulates the Commonwealth of Virginia and the Virginia Innovation Partnership Corporation on a Historic Investment to Create the Nation’s Largest Workforce Development Center for Advanced Pharmaceutical Manufacturing

Recent Comments

No comments to show.

WHY THIS MATTERS
JOIN US

+1 (804) 207-4893

[email protected]

424 Hull St., Suite 400
Richmond, VA 23224

MEDIA INQUIRIES

STAY CONNECTED

  • Follow
  • Follow
  • Follow

To report an adverse event or product complaint associated with Phlow Drug Products, please call (844) 708-2982.

Privacy Policy | Consent Preferences | Additional Resources & Policies